Related references
Note: Only part of the references are listed.Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma
Long-Hai Feng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
MicroRNA profiling of low-grade glial and glioneuronal tumors shows an independent role for cluster 14q32.31 member miR-487b
Heather Marion Ames et al.
MODERN PATHOLOGY (2017)
Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status
Wen Cheng et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b
Rachid El Fatimy et al.
MOLECULAR THERAPY (2017)
Insulator dysfunction and oncogene activation in IDH mutant gliomas
William A. Flavahan et al.
NATURE (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma
Jun Li et al.
EUROPEAN JOURNAL OF CANCER (2016)
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Brigitta G. Baumert et al.
LANCET ONCOLOGY (2016)
Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II/III gliomas
Pei Yang et al.
NEURO-ONCOLOGY (2016)
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C. Buckner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups
Michael Weller et al.
ACTA NEUROPATHOLOGICA (2015)
miRNA-182 and the regulation of the glioblastoma phenotype toward - miRNA-based precision therapeutics
Fotini M. Kouri et al.
CELL CYCLE (2015)
Mutational landscape and clonal architecture in grade II and III gliomas
Hiromichi Suzuki et al.
NATURE GENETICS (2015)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Correlation of microRNA-10b upregulation and poor prognosis in human gliomas
Yuchen Ji et al.
TUMOR BIOLOGY (2015)
RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas
Zhao-Shi Bao et al.
GENOME RESEARCH (2014)
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III
Michela Visani et al.
MOLECULAR ONCOLOGY (2014)
MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IB both in vitro and in vivo
Guang Yang et al.
NEURO-ONCOLOGY (2014)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson et al.
SCIENCE (2014)
Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme
Wei Zhang et al.
CANCER (2013)
Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy
Yizhou Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Oncogenic effects of miR-10b in glioblastoma stem cells
Fadila Guessous et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis
Jia-Xing Zhang et al.
LANCET ONCOLOGY (2013)
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis
Na Liu et al.
LANCET ONCOLOGY (2012)
Human Glioma Growth Is Controlled by MicroRNA-10b
Galina Gabriely et al.
CANCER RESEARCH (2011)
MiRNA-196 Is Upregulated in Glioblastoma But Not in Anaplastic Astrocytoma and Has Prognostic Significance
Yanlei Guan et al.
CLINICAL CANCER RESEARCH (2010)
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
C. Houillier et al.
NEUROLOGY (2010)
Oncogenic role of microRNAs in brain tumors
Jesse Chung-sean Pang et al.
ACTA NEUROPATHOLOGICA (2009)
Prognostic factors for survival in adult patients with cerebral low-grade glioma
F Pignatti et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
